Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SYBX

Synlogic (SYBX)

Synlogic Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SYBX
FechaHoraFuenteTítuloSímboloCompañía
19/03/202406:00GlobeNewswire Inc.Synlogic Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:SYBXSynlogic Inc
22/02/202415:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SYBXSynlogic Inc
20/02/202416:05Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:SYBXSynlogic Inc
20/02/202411:15GlobeNewswire Inc.Synlogic Adopts Limited Duration Stockholders Rights PlanNASDAQ:SYBXSynlogic Inc
16/02/202415:54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SYBXSynlogic Inc
16/02/202415:44Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:SYBXSynlogic Inc
14/02/202414:55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SYBXSynlogic Inc
08/02/202415:15GlobeNewswire Inc.Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateNASDAQ:SYBXSynlogic Inc
02/02/202411:00GlobeNewswire Inc.Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical HomocystinuriaNASDAQ:SYBXSynlogic Inc
04/01/202415:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SYBXSynlogic Inc
04/01/202406:00GlobeNewswire Inc.Synlogic Provides Corporate Update and Outlook for 2024NASDAQ:SYBXSynlogic Inc
27/12/202306:00GlobeNewswire Inc.Synlogic Announces Contract with the Air Force Research LabNASDAQ:SYBXSynlogic Inc
07/12/202306:00GlobeNewswire Inc.Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023NASDAQ:SYBXSynlogic Inc
09/11/202306:00GlobeNewswire Inc.Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:SYBXSynlogic Inc
09/11/202305:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SYBXSynlogic Inc
07/11/202306:00GlobeNewswire Inc.Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche CollaborationNASDAQ:SYBXSynlogic Inc
13/10/202315:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SYBXSynlogic Inc
03/10/202315:15GlobeNewswire Inc.Synlogic Announces Closing of $21.0 Million Underwritten Public OfferingNASDAQ:SYBXSynlogic Inc
02/10/202316:05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SYBXSynlogic Inc
29/09/202306:00GlobeNewswire Inc.Synlogic Announces Pricing of $21.0 Million Underwritten Public OfferingNASDAQ:SYBXSynlogic Inc
28/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SYBXSynlogic Inc
28/09/202320:43Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:SYBXSynlogic Inc
28/09/202310:15GlobeNewswire Inc.Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature MetabolismNASDAQ:SYBXSynlogic Inc
28/09/202307:39Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SYBXSynlogic Inc
27/09/202311:30GlobeNewswire Inc.Synlogic Announces Reverse Stock SplitNASDAQ:SYBXSynlogic Inc
21/09/202306:00GlobeNewswire Inc.Synlogic to Participate in Chardan’s Genetic Medicines ConferenceNASDAQ:SYBXSynlogic Inc
19/09/202310:00GlobeNewswire Inc.Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100NASDAQ:SYBXSynlogic Inc
08/09/202315:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SYBXSynlogic Inc
01/09/202307:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SYBXSynlogic Inc
21/08/202316:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SYBXSynlogic Inc
 Showing the most relevant articles for your search:NASDAQ:SYBX